𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BRCA1 and BRCA2 Variants of Uncertain Significance. Part Two: Medical Management

✍ Scribed by Susan Miller-Samuel; Anne Rosenberg; Adam Berger; Leonard Gomella; David Loren; Gloria J. Morris

Book ID
114474406
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
237 KB
Volume
38
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A review of a multifactorial probability
A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)
✍ Noralane M. Lindor; Lucia Guidugli; Xianshu Wang; Maxime P. VallΓ©e; Alvaro N. A. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 262 KB πŸ‘ 2 views

Clinical mutation screening of the BRCA1 and BRCA2 genes for the presence of germline inactivating mutations is used to identify individuals at elevated risk of breast and ovarian cancer. Variants identified during screening are usually classified as pathogenic (increased risk of cancer) or not path

Assessment of rare BRCA1 and BRCA2 varia
Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling
✍ Marinela Capanu; Patrick Concannon; Robert W. Haile; Leslie Bernstein; Kathleen πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 2 views

Current evidence suggests that the genetic risk of breast cancer may be caused primarily by rare variants. However, while classification of protein-truncating mutations as deleterious is relatively straightforward, distinguishing as deleterious or neutral the large number of rare missense variants i